Cell Reports (Apr 2018)

The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer

  • Phillip M. Shelton,
  • Angeles Duran,
  • Yuki Nakanishi,
  • Miguel Reina-Campos,
  • Hiroaki Kasashima,
  • Victoria Llado,
  • Li Ma,
  • Alex Campos,
  • Damián García-Olmo,
  • Mariano García-Arranz,
  • Dolores C. García-Olmo,
  • Susana Olmedillas-López,
  • Javier F. Caceres,
  • Maria T. Diaz-Meco,
  • Jorge Moscat

Journal volume & issue
Vol. 23, no. 4
pp. 1178 – 1191

Abstract

Read online

Summary: Most colorectal cancer (CRC)-related deaths are due to liver metastases. PKCζ is a tumor suppressor in CRC with reduced expression in metastasis. Given the importance of microRNAs (miRNAs) in regulating cellular plasticity, we performed an unbiased screening and identified the miR-200 family as the most relevant miRNAs downregulated by PKCζ deficiency. The regulation of the intracellular levels of miR-200 by PKCζ is post-transcriptional and involves their secretion in extracellular vesicles. Here, we identified ADAR2 as a direct substrate of PKCζ in CRC cells. Phosphorylation of ADAR2 regulates its editing activity, which is required to maintain miR-200 steady-state levels, suggesting that the PKCζ/ADAR2 axis regulates miR-200 secretion through RNA editing. Loss of this axis results in epithelial-to-mesenchymal transition (EMT) and increased liver metastases, which can be inhibited in vivo by blocking miR-200 release. Therefore, the PKCζ/ADAR2 axis is a critical regulator of CRC metastases through modulation of miR-200 levels. : Shelton et al. demonstrate that the loss of the tumor suppressor PKCζ in colorectal cancer cells results in the downregulation of miR-200, leading to increased epithelial-to-mesenchymal transition, cell invasion, and liver metastasis. This is mediated by an increase in miR-200 secretion through the inactivation of the RNA editing enzyme ADAR2, identifying a key vulnerability in liver metastasis. Keywords: PRKCZ, atypical PKC, ADAR2, colorectal cancer, metastasis, EMT, mir-200, extracellular vesicles, tumor suppressors, RNA editing